We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $445M
1-Year Est. Return 41.72%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+41.72%
3 Year Est. Return
+93.84%
5 Year Est. Return
+130.57%
10 Year Est. Return
+365.42%
AUM
$104M
AUM Growth
+$6.94M
Cap. Flow
+$2.78M
Cap. Flow %
2.67%
Top 10 Hldgs %
32.54%
Holding
115
New
11
Increased
40
Reduced
21
Closed
4

Top Buys

Rank Stock Value
1
YUM icon
Yum! Brands
YUM
+$542K
2
XIFR
XPLR Infrastructure LP
XIFR
+$536K
3
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$417K
4
RH icon
RH
RH
+$395K
5
QQQ icon
Invesco QQQ Trust
QQQ
+$317K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.08M
2
GE icon
GE Aerospace
GE
+$745K
3
GSK icon
GSK
GSK
+$697K
4
XOM icon
ExxonMobil
XOM
+$430K
5
JNJ icon
Johnson & Johnson
JNJ
+$352K

Sector Composition

Rank Sector Weight
1 Healthcare 25.86%
2 Energy 14.81%
3 Financials 10.04%
4 Industrials 9.49%
5 Technology 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
26
AstraZeneca
AZN
$263B
$1.31M 1.26%
19,650
+1,500
+8% +$98.3K
T icon
27
AT&T
T
$159B
$1.31M 1.26%
50,615
-5,104
-9% -$129K
SWK icon
28
Stanley Black & Decker
SWK
$14.3B
$1.29M 1.24%
12,350
– –
PEP icon
29
PepsiCo
PEP
$190B
$1.25M 1.19%
12,607
+307
+2% +$30.6K
ROK icon
30
Rockwell Automation
ROK
$53.4B
$1.23M 1.18%
12,120
+1,500
+14% +$157K
SNY icon
31
Sanofi
SNY
$103B
$1.23M 1.18%
29,150
+1,425
+5% +$65.6K
GRA
32
DELISTED
W.R. Grace & Co.
GRA
$1.18M 1.13%
12,100
– –
BAX icon
33
Baxter International
BAX
$13.5B
$1.18M 1.13%
31,600
+1,500
+5% +$54.8K
NOC icon
34
Northrop Grumman
NOC
$77.1B
$1.17M 1.12%
6,238
– –
DD icon
35
DuPont de Nemours
DD
$18.5B
$1.16M 1.11%
9,189
-1,372
-13% -$176K
CL icon
36
Colgate-Palmolive
CL
$73.1B
$1.1M 1.06%
17,000
– –
ADP icon
37
Automatic Data Processing
ADP
$106B
$1.09M 1.05%
13,300
– –
DD
38
DELISTED
Du Pont De Nemours E I
DD
$1.07M 1.03%
17,028
+482
+3% +$30.6K
AGO icon
39
Assured Guaranty
AGO
$3.66B
$1.06M 1.02%
40,800
-3,500
-8% -$93.9K
PFE icon
40
Pfizer
PFE
$143B
$1.04M 1%
34,287
-34,432
-50% -$1.08M
GE icon
41
GE Aerospace
GE
$374B
$990K 0.95%
6,730
-5,244
-44% -$745K
FMS icon
42
Fresenius Medical Care
FMS
$13.8B
$961K 0.92%
23,288
– –
BRK.B icon
43
Berkshire Hathaway Class B
BRK.B
$1.1T
$876K 0.84%
6,700
– –
HES
44
DELISTED
Hess
HES
$868K 0.83%
18,009
-100
-0.6% -$5.68K
NTCT icon
45
NETSCOUT
NTCT
$2.96B
$820K 0.79%
27,150
+1,996
+8% +$68.6K
BDSI
46
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$789K 0.76%
174,250
+73,500
+73% +$417K
AEP icon
47
American Electric Power
AEP
$69.6B
$769K 0.74%
13,176
+2,226
+20% +$126K
ABBV icon
48
AbbVie
ABBV
$443B
$728K 0.7%
12,643
+1,643
+15% +$94.6K
F icon
49
Ford
F
$58.5B
$703K 0.67%
50,300
– –
SLB icon
50
SLB Ltd
SLB
$73.6B
$692K 0.66%
10,000
– –
1
2
3 4 5

Similar funds

RWM
Rialto Wealth Management Syracuse, New York $445M AUM 15.58% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return
WC
Weil Company San Diego, California $445M AUM 14.95% 1-Year Est. Return
MLIC
Mandatum Life Insurance Company Helsinki, Finland $445M AUM 26.43% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $444M AUM 44.44% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
WCP
Welch Capital Partners Harrison, New York $444M AUM 21.45% 1-Year Est. Return
ACA
Aspire Capital Advisors Seattle, Washington $444M AUM 16.47% 1-Year Est. Return

Searle & Co's Q4 2015 Portfolio in Review

As of Q4 2015, Searle & Co held 115 positions worth $104M, up 7.1% from $97.3M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Searle & Co's Q4 2015 filing shows 11 new, 40 increased, 21 reduced and 4 closed positions. Its largest new stake was RH: 4,250 shares worth $332K. The largest sale was Pfizer, an estimated $1.08M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Energy and Financials.

  • Searle & Co's largest Q4 2015 buy was RH: 4,250 shares worth $332K.
  • Searle & Co added most to Yum! Brands in Q4 2015, an estimated $542K increase.
  • Searle & Co's biggest Q4 2015 reduction was Pfizer, cutting an estimated $1.08M.
  • Searle & Co fully exited GSK in Q4 2015, selling an estimated $697K.
  • Searle & Co's ten largest holdings make up 33% of its $104M portfolio in Q4 2015.
  • Searle & Co opened 11 new positions and closed 4 in Q4 2015.
  • Searle & Co's portfolio value rose 7.1% quarter-over-quarter to $104M.

Based on Searle & Co's 13F filing for Q4 2015, filed 11 Jan 2016.